The 12th Invest in ME Research Conference June, 2017, Part 2
MEMum presents the second article in a series of three about the recent 12th Invest In ME International Conference (IIMEC12) in London.
Discuss the article on the Forums.

Heart Medication Recalled Due To Contamination With Carcinogen

Discussion in 'General Treatment' started by YippeeKi YOW !!, Nov 2, 2018.

  1. YippeeKi YOW !!

    YippeeKi YOW !! Senior Member

    Second star to the right ...
    Irbesartan, used to treat high blood pressure and hypertension, has had 22 batches voluntarily recalled, due to trace amounts of NDEA (N-nitrosodiethylamine) on behalf of Sciegen Pharmaceuticals.

    Here's the entire text of the article I bumped into:

    From Delish

    If you take a medicine called Irbesartan, used to treat high blood pressure and hypertension, you'll want to check the label. The FDA announced a voluntary recall of the drug due to trace amounts of the NDEA (N-nitrosodiethylamine) on behalf of Sciegen Pharmaceuticals.

    The substance occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and it has been classified as a probable human carcinogen by the International Agency for Research on Cancer.

    Twenty-two batches of the drug, with distribution dates between January 2016 and December 2017, were recalled. The bottles affected are labeled "Westminster Pharmaceuticals" or "GSMS Incorporated," and are 30- or 90-count bottles of 75mg, 150mg, or 300mg tablets. The FDA has full details of the bottles affected, including the lot number, on its website.

    If you do have one of the affected bottles, contact your doctor before you stop taking the medicine, the announcement says. "The risk of harm to a patient’s health may be higher if the treatment is stopped immediately without any alternative treatment."
    Photo credit: FDA

    Here's a link to the FDA page with full details
    Last edited: Nov 2, 2018

See more popular forum discussions.

Share This Page